Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biochemical Journal

• Publication date

  2009-01-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ20081013PMID 18816248PMCID PMC2680709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation of Tyrosine 801 of Vascular Endothelial Growth Factor Receptor-2 Is Necessary for Akt-dependent Endothelial Nitric-oxide Synthase Activation and Nitric Oxide Release from Endothelial Cells*

  2007cited by this paper
• Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1.

  2007cited by this paper
• Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.

  2006cited by this paper
• Dissociation of endothelial nitric oxide synthase phosphorylation and activity in uterine artery endothelial cells.

  2006cited by this paper
• Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

  2006cited by this paper
• Pregnancy-enhanced Ca2+ responses to ATP in uterine artery endothelial cells is due to greater capacitative Ca2+ entry rather than altered receptor coupling.

  2006cited by this paper
• Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner.

  2006cited by this paper
• Pregnancy-enhanced store-operated Ca 2 C channel function in uterine artery endothelial cells is associated with enhanced agonist-specific transient receptor potential channel 3-inositol 1,4,5-trisphosphate receptor 2 interaction

  2006cited by this paper
• VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways.

  2006cited by this paper
• Pregnancy-enhanced endothelial nitric oxide synthase (eNOS) activation in uterine artery endothelial cells shows altered sensitivity to Ca2+, U0126, and wortmannin but not LY294002--evidence that pregnancy adaptation of eNOS activation occurs at multiple levels of cell signaling.

  2006cited by this paper
• Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide–Mediated Angiogenesis

  2006cited by this paper
• Circulating Angiogenic Factors and the Risk of Preeclampsia

  2005cited by this paper
• Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.

  2005cited by this paper
• Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy

  2005cited by this paper
• Soluble Vascular Endothelial Growth Factor Receptor-1 (sFLT-1) Mediates Downregulation of FLT-1 and Prevents Activated Neutrophils From Women With Preeclampsia From Additional Migration by VEGF

  2005cited by this paper
• Exogenous Vascular Endothelial Growth Factor Can Induce Preeclampsia-Like Symptoms in Pregnant Mice

  2005cited by this paper
• Molecular Cloning of Ovine Endothelial Nitric Oxide Synthase and Expression in COS-7 Cells

  2005cited by this paper
• Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration

  2005cited by this paper
• Changes in Expression of Vascular Endothelial Growth Factor and Its Receptors in Neonatal Hypoxia-Induced Pulmonary Hypertension

  2005cited by this paper
• Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation

  2004cited by this paper
• Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.

  2004cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Pregnancy-specific changes in uterine artery endothelial cell signaling in vivo are both programmed and retained in primary culture.

  2003cited by this paper
• Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function.

  2003cited by this paper
• Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia

  2003cited by this paper
• VEGF signalling: integration and multi-tasking in endothelial cell biology.

  2003cited by this paper
• Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells.

  2002cited by this paper
• Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy.

  2002cited by this paper
• Pitfalls in the measurement of circulating vascular endothelial growth factor.

  2001cited by this paper
• Pregnancy-Specific Enhancement of Agonist-Stimulated ERK-1/2 Signaling in Uterine Artery Endothelial Cells Increases Ca2+ Sensitivity of Endothelial Nitric Oxide Synthase as well as Cytosolic Phospholipase A2.

  2001cited by this paper
• Pregnancy-specific enhancement of agonist-stimulated ERK-1/2 signaling in uterine artery endothelial cells increases Ca(2+) sensitivity of endothelial nitric oxide synthase as well as cytosolic phospholipase A(2).

  2001cited by this paper
• Angiogenesis in the placenta.

  2001cited by this paper
• Mechanism by which wortmannin and LY294002 inhibit catecholamine secretion in the rat adrenal medullary cells.

  2001cited by this paper
• Regulation of epidermal growth factor receptor endocytosis by wortmannin through activation of Rab5 rather than inhibition of phosphatidylinositol 3‐kinase

  2001cited by this paper
• Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Phosphoinositides Are Required for Store-mediated Calcium Entry in Human Platelets*

  2000cited by this paper
• Pregnancy-dependent changes in cell signaling underlie changes in differential control of vasodilator production in uterine artery endothelial cells.

  2000cited by this paper
• Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth.

  1999cited by this paper
• Preeclampsia: The Endothelium, Circulating Factor(s) and Vascular Endothelial Growth Factor

  1999cited by this paper
• A novel vascular endothelial growth factor encoded by Orf virus, VEGF‐E, mediates angiogenesis via signalling through VEGFR‐2 (KDR) but not VEGFR‐1 (Flt‐1) receptor tyrosine kinases

  1999cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• A Novel Type of Vascular Endothelial Growth Factor, VEGF-E (NZ-7 VEGF), Preferentially Utilizes KDR/Flk-1 Receptor and Carries a Potent Mitotic Activity without Heparin-binding Domain*

  1998cited by this paper
• Maternal Cardiovascular and Other Physiologic Responses to the Endocrinology of Pregnancy

  1998cited by this paper
• Human Phosphoinositide 3-Kinase C2β, the Role of Calcium and the C2 Domain in Enzyme Activity*

  1998cited by this paper
• The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts

  1997cited by this paper
• Wortmannin inhibits store‐mediated calcium entry and protein tyrosine phosphorylation in human platelets

  1996cited by this paper
• Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes.

  1995cited by this paper
• THE PHYSIOLOGY OF PRE‐ECLAMPSIA

  1995cited by this paper
• Wortmannin and Its Structural Analogue Demethoxyviridin Inhibit Stimulated Phospholipase A2 Activity in Swiss 3T3 Cells

  1995cited by this paper
• Word Count: 4,574 Correspondence and Print Requests to:

  year unknowncited by this paper

• Trophoblast Function in Preeclampsia: Decoding the Mechanistic Roles of Coding and Non-Coding Genes

  2025influential citation
• DOCK1 deficiency drives placental trophoblast cell dysfunction by influencing inflammation and oxidative stress, hallmarks of preeclampsia

  2024cites this paper
• Deciphering the immunological interactions: targeting preeclampsia with Hydroxychloroquine’s biological mechanisms

  2024cites this paper
• Creating mini-pregnancy models in vitro with clinical perspectives

  2023cites this paper
• Sphingosine 1-Phosphate Activates S1PR3 to Induce a Proinflammatory Phenotype in Human Myometrial Cells

  2023cites this paper
• AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells

  2022cites this paper
• Vascular Dysfunction in Preeclampsia

  2021cites this paper
• Bisphenol a Interferes with Uterine Artery Features and Impairs Rat Feto-Placental Growth

  2021cites this paper
• Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation

  2021cites this paper
• S‐Nitrosoglutathione Reductase Deficiency Causes Aberrant Placental S‐Nitrosylation and Preeclampsia

  2020cites this paper
• Conjugated linoleic acid improves endothelial Ca2+ signaling by blocking growth factor and cytokine-mediated Cx43 phosphorylation.

  2020cites this paper
• Adenoviral transduction of EGFR into pregnancy-adapted uterine artery endothelial cells remaps growth factor induction of endothelial dysfunction.

  2020cites this paper
• Gasotransmitters in pregnancy: from conception to uterine involution†

  2019cites this paper
• Sympathetic nervous system control of vascular function and blood pressure during pregnancy and preeclampsia.

  2019influential citation
• TNF-alpha inhibits pregnancy-adapted Ca2+ signaling in uterine artery endothelial cells.

  2019cites this paper
• Maternal Complications of Pregnancy that Affect Fetal Development

  2018cites this paper
• Exploitation of receptor tyrosine kinases by viral-encoded growth factors

  2018cites this paper
• Compartmentalized Culture of Perivascular Stroma and Endothelial Cells in a Microfluidic Model of the Human Endometrium

  2017cites this paper
• The Potential Role of Oxidative Stress in Reduced Uterine Perfusion Pressure Vascular Reactivity

  2017cites this paper
• Effects of kallidinogenase on retinal edema and size of non-perfused areas in mice with retinal vein occlusion.

  2017cites this paper
• Positive versus negative effects of VEGF165 on Ca2+ signaling and NO production in human endothelial cells.

  2017cites this paper
• Superimposed Preeclampsia.

  2017cites this paper
• Vascular Biology and Microcirculation Positive versus negative effects of VEGF 165 on Ca 2 (cid:2) signaling and NO production in human endothelial cells

  2016cites this paper
• Effect of Altered VEGFR2 Expression on Oxidative Stress in a Rodent Model of Preeclampsia Pathology

  2016cites this paper
• A cystine-knot miniprotein from tomato fruit inhibits endothelial cell migration and angiogenesis by affecting vascular endothelial growth factor receptor (VEGFR) activation and nitric oxide production.

  2015cites this paper
• Phosphorylation of Ser-279/282 and Tyr-265 positions on Cx43 as possible mediators of VEGF-165 inhibition of pregnancy-adapted Ca2+ burst function in ovine uterine artery endothelial cells.

  2015cites this paper
• Pregnancy programming and preeclampsia: identifying a human endothelial model to study pregnancy-adapted endothelial function and endothelial adaptive failure in preeclamptic subjects.

  2014cites this paper
• Altered VEGF-stimulated Ca2+ signaling in part underlies pregnancy-adapted eNOS activity in UAEC.

  2014cites this paper
• Artery Endothelium: Relative roles in pregnancy adaptation and reversal by

  2011cites this paper
• Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A165 in the uterine arteries of pregnant sheep

  2011cites this paper
• The effects of VEGF overexpression on the utero-placentalcirculation

  2011cites this paper
• The assessment of endothelial function in pregnancy by flow-mediated dilatation.

  2011cites this paper
• Pregnancy Adaptive Programming of Capacitative Entry Responses

  2011cites this paper
• eNOS activation and NO function: pregnancy adaptive programming of capacitative entry responses alters nitric oxide (NO) output in vascular endothelium--new insights into eNOS regulation through adaptive cell signaling.

  2011cites this paper
• Cardiovascular effects of nerve growth factor: An analytical review. Part II

  2011cites this paper
• Endothelial-Derived Hyperpolarization Factor (EDHF) Contributes to PlGF-Induced Dilation of Mesenteric Resistance Arteries from Pregnant Rats

  2011cites this paper
• [Ca2+]i signaling vs. eNOS expression as determinants of NO output in uterine artery endothelium: relative roles in pregnancy adaptation and reversal by VEGF165.

  2011cites this paper
• eNOS activation and NO function: Pregnancy adaptive programming of capacitative entry responses alters nitric oxide (NO) output in vascular endothelium–new insights into eNOS regulation through adaptive cell signaling

  2011cites this paper
• Pregnancy Induced Reprogramming of Endothelial Function in Response to ATP: Evidence for Post Receptor Ca2+ Signaling Plasticity

  2010cites this paper
• Signaling vs eNOS Expression as Determinants of NO Output In Uterine 1 Artery Endothelium : Relative roles in pregnancy adaptation and reversal by 2 VEGF 165 . 3 4 5

  2010cites this paper
• Estradiol-17&bgr; and Its Cytochrome P450- and Catechol-O-Methyltransferase–Derived Metabolites Stimulate Proliferation in Uterine Artery Endothelial Cells: Role of Estrogen Receptor-&agr; Versus Estrogen Receptor-&bgr;

  2010cites this paper
• HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells.

  2009cites this paper
• Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro.

  2009cites this paper
• A glance over the cannabinoid machinery to design new anti-angiogenic compounds.

  2009cites this paper
• The Effect of Magnesium Sulfate (MgSO4) Administration on Nitric Oxide and Prostacyclin Levels in Preeclampsia

  year unknowncites this paper